Plus   Neg

AMAG Pharmaceuticals Inc. (AMAG) Jumped After FDA Approval

AMAG Pharmaceuticals Inc. (AMAG) announced Wednesday that the FDA has approved the Makena subcutaneous auto-injector drug-device combination product.

AMAG Pharmaceuticals gapped up sharply Wednesday and climbed throughout the morning. Shares finished with a gain of 4.05 at $17.95 on the highest volume of the year. The stock broke out to a 4-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT